These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32950646)

  • 1. Silymarin is an ally against insulin resistance: A review.
    MacDonald-Ramos K; Michán L; Martínez-Ibarra A; Cerbón M
    Ann Hepatol; 2021; 23():100255. PubMed ID: 32950646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milk thistle (Silybum marianum) for the therapy of liver disease.
    Flora K; Hahn M; Rosen H; Benner K
    Am J Gastroenterol; 1998 Feb; 93(2):139-43. PubMed ID: 9468229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review.
    Tajmohammadi A; Razavi BM; Hosseinzadeh H
    Phytother Res; 2018 Oct; 32(10):1933-1949. PubMed ID: 30015401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
    Federico A; Dallio M; Loguercio C
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin.
    Islam A; Mishra A; Siddiqui MA; Siddiquie S
    Drug Res (Stuttg); 2021 Nov; 71(9):489-503. PubMed ID: 34318464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitargeted therapy of cancer by silymarin.
    Ramasamy K; Agarwal R
    Cancer Lett; 2008 Oct; 269(2):352-62. PubMed ID: 18472213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.
    Abenavoli L; Izzo AA; Milić N; Cicala C; Santini A; Capasso R
    Phytother Res; 2018 Nov; 32(11):2202-2213. PubMed ID: 30080294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic potentials of milk thistle (Silybum marianum).
    Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
    Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography-drift tube ion mobility-mass spectrometry as a new challenging tool for the separation and characterization of silymarin flavonolignans.
    Fenclova M; Stranska-Zachariasova M; Benes F; Novakova A; Jonatova P; Kren V; Vitek L; Hajslova J
    Anal Bioanal Chem; 2020 Feb; 412(4):819-832. PubMed ID: 31919606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of therapeutic potentials of milk thistle (
    Emadi SA; Ghasemzadeh Rahbardar M; Mehri S; Hosseinzadeh H
    Iran J Basic Med Sci; 2022 Oct; 25(10):1166-1176. PubMed ID: 36311193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection.
    Morishima C; Shuhart MC; Wang CC; Paschal DM; Apodaca MC; Liu Y; Sloan DD; Graf TN; Oberlies NH; Lee DY; Jerome KR; Polyak SJ
    Gastroenterology; 2010 Feb; 138(2):671-81, 681.e1-2. PubMed ID: 19782083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
    Bijak M
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.
    Koltai T; Fliegel L
    J Evid Based Integr Med; 2022; 27():2515690X211068826. PubMed ID: 35018864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of silibinin in the rat liver.
    Colturato CP; Constantin RP; Maeda AS; Constantin RP; Yamamoto NS; Bracht A; Ishii-Iwamoto EL; Constantin J
    Chem Biol Interact; 2012 Jan; 195(2):119-32. PubMed ID: 22137898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the SIRT1 pathway and modulation of the cell cycle were involved in silymarin's protection against UV-induced A375-S2 cell apoptosis.
    Li LH; Wu LJ; Tashiro SI; Onodera S; Uchiumi F; Ikejima T
    J Asian Nat Prod Res; 2007; 9(3-5):245-52. PubMed ID: 17566917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review).
    Vaid M; Katiyar SK
    Int J Oncol; 2010 May; 36(5):1053-60. PubMed ID: 20372777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention.
    Bellavite P; Fazio S; Affuso F
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37298967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion.
    Zhao J; Sharma Y; Agarwal R
    Mol Carcinog; 1999 Dec; 26(4):321-33. PubMed ID: 10569809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer potential of silymarin: from bench to bed side.
    Agarwal R; Agarwal C; Ichikawa H; Singh RP; Aggarwal BB
    Anticancer Res; 2006; 26(6B):4457-98. PubMed ID: 17201169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the use of milk thistle (Silybum marianum).
    Post-White J; Ladas EJ; Kelly KM
    Integr Cancer Ther; 2007 Jun; 6(2):104-9. PubMed ID: 17548789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.